[Epidemiological and clinical outlook of chronic Chagas' heart disease in Mexico]

Justo Sierra-Johnson1, Amonario Olivera-Mar, Víctor M Monteón-Padilla

  • 1Instituto Nacional de Cardiología Ignacio Chávez, Mexico, DF, Mexico.

Revista De Saude Publica
|October 29, 2005
PubMed

Insights

Chronic Chagas' heart disease, caused by Trypanosoma cruzi, is a significant cause of dilated cardiomyopathy. This study highlights its distinct epidemiological and clinical features compared to other cardiomyopathies.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Dilated cardiomyopathy is a significant cause of heart failure.
  • Chagas' disease, caused by *Trypanosoma cruzi*, is a leading cause of heart disease in endemic regions.
  • Understanding the specific characteristics of Chagas' heart disease is crucial for diagnosis and management.

Purpose of the Study:

  • To compare the epidemiological and clinical profiles of chronic Chagas' heart disease with other forms of dilated cardiomyopathy.
  • To identify distinguishing features of Chagas' heart disease.

Main Methods:

  • A retrospective study of 128 patients (51 *Trypanosoma cruzi* positive) from 1993-2003.
  • Data collection included interviews for epidemiological data and health service records for clinical and serological information.
  • Statistical analysis employed Chi-square, Fischer, Mann-Whitney, Student's t-tests, and multivariate analysis.

Main Results:

  • Chagas' disease patients were older (55 vs. 42 years), more likely from rural areas (90% vs. 68%), and lived in poorer, crowded conditions.
  • ECG abnormalities (rhythm, conduction) and pacemaker use were more common in Chagas' patients (84%, 78%, 24% vs. 55%, 64%, 10%).
  • Congestive heart failure was more frequent in other cardiomyopathies (88% vs. 71%), while comorbidities were rarer in Chagas' disease.

Conclusions:

  • Chronic Chagas' disease is the predominant cause of dilated cardiomyopathy at the study hospital.
  • Given its regional prevalence in Mexico, Chagas' disease warrants targeted attention and control strategies.
  • Effective control programs, successful elsewhere, should be considered for implementation.
Abstract

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...